Design, synthesis, and anticonvulsant effects evaluation of nonimidazole histamine H3 receptor antagonists/inverse agonists containing triazole moiety-Reference-Cited by-同舟云学术

Design, synthesis, and anticonvulsant effects evaluation of nonimidazole histamine H3 receptor antagonists/inverse agonists containing triazole moiety

Published:2020-01-01 Issue:1 Volume:35 Page:1310-1321
ISSN:1475-6366
Container-title:Journal of Enzyme Inhibition and Medicinal Chemistry
language:en
Short-container-title:Journal of Enzyme Inhibition and Medicinal Chemistry

Author:

Song Mingxia¹,Yan Rui¹,Zhang Yanhui¹,Guo Dongfu¹,Zhou Naiming²,Deng XianQing¹

Affiliation:

1. Medical College, Jinggangshan University, Ji’an, China

2. College of Life Sciences, Zhejiang University, Hangzhou, China

Funder

National Natural Science Foundation of China

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14756366.2020.1774573

Reference48 articles.

1. Addressing the burden of epilepsy: Many unmet needs

2. The Long-Term Safety of Antiepileptic Drugs

3. Antiepileptic drugs and adverse skin reactions: An update

4. Antiepileptic Drugs and Suicide: A Systematic Review of Adverse Effects

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reproductive and fetal toxicity studies of histamine H3 receptor antagonist DL76 used in mice to prevent maximal electroshock-induced seizure;Frontiers in Pharmacology;2024-06-05

2. New Schiff bases derived from dimethylpyridine-1,2,4-triazole hybrid as cytotoxic agents targeting gastrointestinal cancers: Design, synthesis, biological evaluation and molecular docking studies;Bioorganic Chemistry;2023-10

3. An Active Group with Potential Anti-seizure Activity: A Review on 1,2,4- Triazoles;Letters in Drug Design & Discovery;2023-08

4. Antiseizure Properties of Histamine H3 Receptor Antagonists Belonging 3,4-Dihydroquinolin-2(1H)-Ones;Molecules;2023-04-12

5. Advances in Epilepsy: Mechanisms, Clinical Trials, and Drug Therapies;Journal of Medicinal Chemistry;2023-04-04